Cargando…
Side-By-Side Evaluation of Three Commercial ELISAs for the Quantification of SARS-CoV-2 IgG Antibodies
In December 2020, WHO presented the first international standard (WHO IS) for anti-SARS-CoV-2 immunoglobulin. This standard is intended to serve as a reference reagent against which serological tests can be calibrated, thus creating better comparability of results between different tests, laboratori...
Autores principales: | Girl, Philipp, Mantel, Sonja, von Buttlar, Heiner, Wölfel, Roman, Müller, Katharina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953933/ https://www.ncbi.nlm.nih.gov/pubmed/35336984 http://dx.doi.org/10.3390/v14030577 |
Ejemplares similares
-
Comparison of two commercial surrogate ELISAs to detect a neutralising antibody response to SARS-CoV-2
por: Müller, Katharina, et al.
Publicado: (2021) -
Evaluation of Two Rapid Lateral Flow Tests and Two Surrogate ELISAs for the Detection of SARS-CoV-2 Specific Neutralizing Antibodies
por: Girl, Philipp, et al.
Publicado: (2022) -
Sensitivity of two SARS-CoV-2 variants with spike protein mutations to neutralising antibodies
por: Müller, Katharina, et al.
Publicado: (2021) -
Emerging SARS-CoV-2 variant B.1.1.7 reduces neutralisation activity of antibodies against wild-type SARS-CoV-2
por: Müller, Katharina, et al.
Publicado: (2021) -
Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG
por: Sapkal, Gajanan, et al.
Publicado: (2020)